Monte Rosa Therapeutics, Inc.

Historical 13F Holders

Symbol
GLUE
CUSIP
61225M102
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 135 60.1 M $445 M
2025 Q2 119 62.7 M $283 M
2025 Q1 111 59.5 M $276 M
2024 Q4 111 61.0 M $423 M
2024 Q3 86 49.8 M $264 M
2024 Q2 81 45.9 M $172 M
2024 Q1 76 40.0 M $282 M
2023 Q4 83 40.2 M $227 M
2023 Q3 76 42.0 M $201 M
2023 Q2 71 39.7 M $272 M
2023 Q1 72 39.8 M $310 M
2022 Q4 72 41.8 M $318 M
2022 Q3 72 40.4 M $330 M
2022 Q2 58 38.8 M $375 M
2022 Q1 54 40.0 M $561 M
2021 Q4 54 36.3 M $742 M
2021 Q3 57 34.9 M $759 M
2021 Q2 49 32.1 M $705 M